Glenmark

Glenmark News

Pharmaceutical sector, Indian pharmaceutical sector, India colombo relations, health news, pharma news,

Glenmark USA continues to expand its Over-The-Counter Portfolio with acquisition of new drugs from Wockhardt Limited

Currently, Glenmark’s portfolio consists of 175 products authorized for distribution in the U.S. marketplace and 48 ANDAs pending approval with…

June 28, 2022 14:02 IST

Glenmark receives DCGI approval for conducting Phase 1 Clinical Trial of GRC 54276 in oncology patients

Phase 1 clinical trial is aimed at determining preliminary anti-tumor activity of its novel molecule in patients with advanced solid…

April 11, 2022 12:33 IST

Glenmark raises industry’s first sustainability-linked loan of USD 228 million

Bank of America, the sole underwriter of the entire loan, has extended USD 50 million, and Cincinnati, Ohio-based Fifth Third…

March 22, 2022 17:26 IST

Glenmark Life Sciences IPO, Glenmark Pharma

Glenmark Life Sciences IPO opens July 27, IPO size reduced; plans to sell now 63 lakh shares via OFS

Glenmark Life Sciences’, a subsidiary of Glenmark Pharmaceuticals, IPO will open for subscription next week on 27 July and close…

July 20, 2021 14:30 IST

Glenmark Q4 net profit up 6 pc at Rs 233.87 cr

The company has in place strategic levers to grow its businesses sustainably, with a focus on strengthening its balance sheet,…

May 29, 2021 13:50 IST

Glenmark launches offer to raise up to $200 million

Glenmark Pharmaceuticals today launched an offer on the Singapore Stock Exchange to raise up to USD 200 million (over Rs…

May 31, 2016 18:43 IST

Glenmark launches ‘Digihaler’ for asthma and COPD medication

The next-gen digital inhaler provides accurate digital dose counter along with low dose warning indicator to track patience adherence Glenmark…

May 25, 2016 16:35 IST

IPA announces new office bearers

The IPA, initially formed by eight national companies in November 1999 has now 20 research-based national pharmaceutical companies in its…

April 21, 2016 14:33 IST

Delhi HC questions govt over urgency to ban over 300 FDC drugs

Additional Solicitor General was responding to the contentions of pharma companies like Pfizer, Glenmark, Procter and Gamble and Cipla

April 19, 2016 10:37 IST

Glenmark gets final FDA nod for migraine headache relief drug

Glenmark Pharma has received final nod from the USFDA to manufacture and market therapeutical equivalent of Endo Pharmaceutical’s Frova tablets,…

Updated: March 14, 2016 15:17 IST

Top 5 stocks that remained in news today: Quick Heal, Glenmark Pharma and more

Quick Heal Technologies made a weak stock market debut on Thursday. Quick Heal share price closed 20.73 per cent down…

Updated: February 18, 2016 17:15 IST

Glenmark starts studies on new drug aimed at cancer treatment

The novel clinical development candidate, GBR1342 is an antibody based on the company’s proprietary BEAT platform, Glenmark Pharmaceuticals said in…

January 8, 2016 13:17 IST

Glenmark shares gain on USFDA’s tentative nod for Sanofi’s generic Multaq

Glenmark Pharmaceuticals shares gained over 2 per cent in morning trade on Wednesday after the company received a tentative nod…

Updated: January 6, 2016 17:21 IST

Glenmark gets tentative FDA nod for Sanofi’s generic Multaq

However, the company cannot sell the product in the US as it is involved in a patent litigation with Sanofi…

January 6, 2016 11:38 IST

Glenmark gets USFDA final nod for anti-bacterial drug

Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the US Food & Drug Administration (USFDA) for the Linezolid…

December 22, 2015 12:35 IST

Glenmark settles patent litigation over anti-depressant drug

Glenmark and its US arm Glenmark Pharmaceuticals Inc have entered into a settlement agreement with Forest Laboratories LLC, Forest Laboratories…

December 21, 2015 12:57 IST

Glenmark gets tentative USFDA nod for Lacosamide tablets

Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator for its Lacosamide tablets.

October 30, 2015 11:30 IST

Glenmark’s bi-apecific antibody – GBR 1302 to enter Phase I trials

Glenmark expects to obtain approval for the initiation of clinical studies with GBR1302 during this financial year Glenmark Pharmaceuticals S.A.…

September 15, 2015 17:47 IST

Glenmark stocks rise to record; USFDA gives nod for oral contraceptive drug

Shares of Glenmark Pharmaceuticals rose 5.9 per cent intraday to mark its record high as it received final approval from…

Updated: August 19, 2015 17:33 IST

Glenmark receives USFDA nod for oral contraceptive drug

Glenmark Pharmaceuticals today said it has received final approval from the US health regulator to sell oral contraceptive — drospirenone…

August 19, 2015 12:00 IST

Outperform on Glenmark; one of our top mid-cap picks: IDFC Securities

Glenmark’s consolidated revenues grew by 11% yoy to Rs 1,660 crore (in line), led by LatAm (+86%) and India (+19%).

Updated: August 4, 2015 08:52 IST

US court rejects Glenmark’s patent plea for Finacea

Drug firm Glenmark’s generic skin care drug that was under patent litigation infinges patent of Bayer, a US court has…

July 29, 2015 14:07 IST

Loading…

Something went wrong. Please refresh the page and/or try again.